AMICUS THERAPEUTICS $2.50

down -0.02


19/6/2013 03:19 PM  |  NASDAQ : FOLD  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
3/15/2013 Crowley John F Chairman & CEO 18,506 $3.49 19.50%
3/15/2013 BARER SOL J Director 25,000 $3.40 125.00%
7/17/2012 GLAXOSMITHKLINE PLC Substantial Shareholder 2,949,581 $6.30 42.96%
3/30/2012 Crowley John F Chairman & CEO 49,931 $0.64 506.04%
3/7/2012 BARRETT M JAMES Senior Executive Officer 925,154 $5.70 25.28%
3/7/2012 PERRY MARK W TenPercent 925,154 $5.70 25.28%
3/7/2012 PERRY MARK W TenPercent 214,846 $5.70 25.24%
3/7/2012 NEWHALL CHARLES W III TenPercent 925,154 $5.70 25.28%
3/7/2012 NEWHALL CHARLES W III TenPercent 214,846 $5.70 25.24%
3/7/2012 KRAMLICH C RICHARD TenPercent 925,154 $5.70 25.28%
3/7/2012 KRAMLICH C RICHARD TenPercent 214,846 $5.70 25.24%
3/7/2012 BARRIS PETER J TenPercent 925,154 $5.70 25.28%
3/7/2012 BARRIS PETER J TenPercent 214,846 $5.70 25.24%
3/7/2012 NEW ENTERPRISE ASSOCIATES 11 LP TenPercent 925,154 $5.70 25.28%
8/11/2011 Crowley John F Chairman & CEO 10,000 $4.20 10.01%
6/17/2011 Crowley John F Executive Chairman 20,000 $6.04 25.04%
5/24/2011 Valenzano Ken VP, Pharmacology & Biology 2,250 $0.64 131.73%
5/24/2011 Valenzano Ken VP, Pharmacology & Biology -2,250 $7.50 -56.85%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (FOLD), click here.
Marketplace
Trading Center